Jacobs Levy Equity Management Inc. Boosts Stock Holdings in Arteris, Inc. $AIP

Key Points

• Jacobs Levy Equity Management Inc. increased its stake in Arteris, Inc. by 48.5%, acquiring an additional 81,516 shares, resulting in a total ownership of approximately 0.60% of the company valued at $1.72 million.
• Several hedge funds have significantly altered their positions in Arteris, with CWM LLC increasing its stake by an impressive 4,810.1%.
• Equities analysts are largely optimistic, with three analysts giving Arteris a Buy rating and a consensus target price of $15.00, despite some recent downgrades.

Jacobs Levy Equity Management Inc. boosted its stake in Arteris, Inc. (NASDAQ:AIP - Free Report) by 48.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 249,517 shares of the company's stock after purchasing an additional 81,516 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.60% of Arteris worth $1,724,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. CWM LLC increased its holdings in Arteris by 4,810.1% in the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after purchasing an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. acquired a new position in shares of Arteris in the first quarter worth $95,000. D. E. Shaw & Co. Inc. acquired a new position in shares of Arteris in the fourth quarter worth $110,000. Price T Rowe Associates Inc. MD acquired a new position in shares of Arteris in the fourth quarter worth $117,000. Finally, PVG Asset Management Corp acquired a new position in shares of Arteris in the fourth quarter worth $151,000. Institutional investors and hedge funds own 64.36% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have commented on AIP. Wall Street Zen upgraded shares of Arteris from a "sell" rating to a "hold" rating in a research note on Monday. TD Cowen lifted their price objective on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $14.00 price objective on shares of Arteris in a research report on Wednesday, May 21st. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $15.00.

Insiders Place Their Bets

In other news, major shareholder Bayview Legacy, Llc sold 50,000 shares of the company's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total value of $656,000.00. Following the completion of the sale, the insider directly owned 9,839,071 shares of the company's stock, valued at approximately $129,088,611.52. This represents a 0.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO K Charles Janac sold 94,245 shares of the company's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.49, for a total transaction of $1,271,365.05. Following the completion of the sale, the chief executive officer directly owned 189,785 shares of the company's stock, valued at $2,560,199.65. The trade was a 33.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 510,616 shares of company stock valued at $5,979,663. 33.70% of the stock is owned by insiders.

Arteris Stock Performance

Shares of AIP stock traded up $0.20 during mid-day trading on Tuesday, hitting $9.13. 489,878 shares of the stock were exchanged, compared to its average volume of 510,461. The stock's fifty day simple moving average is $9.46 and its two-hundred day simple moving average is $8.21. The stock has a market capitalization of $389.39 million, a price-to-earnings ratio of -11.13 and a beta of 1.44. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $14.29.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The company had revenue of $16.50 million for the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Arteris Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.